Skip to main navigation Skip to search Skip to main content

Cuba’s COVID-19 Vaccine Enterprise: Report from a High-Level Fact-Finding Delegation to Cuba

  • Michael T. Osterholm
  • , Cristina Rabadán-Diehl
  • , Joshua Anzinger
  • , Maria Elena Bottazzi
  • , Celia Christie-Samuels
  • , Ngozi Erondu
  • , Jeanne Marrazzo
  • , Sandra Milan
  • , Peter Kojo Quashie
  • , Thomas Schwaab
  • , David Williams

Research output: Contribution to journal › Article › peer-review

Abstract

In June 2022 an international delegation of scientists from the United States, the Caribbean and Africa traveled to Havana, Cuba for a three-day fact-finding mission to better understand Cuba’s COVID-19 vaccine development and vaccination efforts. It was the first time in five years that a scientific delegation with significant US presence had engaged in discussions with medical researchers in Cuba. It also included African and Caribbean members to ensure there was a diversity of scientific and public health perspectives. Together, delegation members represented a broad range of expertise in public health systems, infectious diseases, biotechnology, and vaccine development.

Original languageEnglish (US)
JournalMEDICC Review
Volume24
Issue number3-4
DOIs
StatePublished - Jul 2022

Bibliographical note

Funding Information:
Activities of this MED 阀☀☀ fact-finding delegation were supported in part by a grant from the Open Society Foundations. Delegation members issuing the report are solely responsible for its content.

Publisher Copyright:
© 2022 MEDICC Medical Education Cooperation with Cuba. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Cuba’s COVID-19 Vaccine Enterprise: Report from a High-Level Fact-Finding Delegation to Cuba'. Together they form a unique fingerprint.

Cite this